Your browser doesn't support javascript.
loading
Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder.
Berendse, Kevin; Koot, Bart G P; Klouwer, Femke C C; Engelen, Marc; Roels, Frank; Lacle, Miangela M; Nikkels, Peter G J; Verheij, Joanne; Poll-The, Bwee Tien.
Affiliation
  • Berendse K; Department of Paediatric Neurology, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam, Amsterdam, The Netherlands.
  • Koot BGP; Department of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Klouwer FCC; Department of Paediatric Neurology, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam, Amsterdam, The Netherlands.
  • Engelen M; Department of Paediatric Neurology, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam, Amsterdam, The Netherlands.
  • Roels F; Department of Human Anatomy and Embryology, Ghent University, Ghent, Belgium.
  • Lacle MM; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Nikkels PGJ; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Verheij J; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
J Inherit Metab Dis ; 42(5): 955-965, 2019 09.
Article in En | MEDLINE | ID: mdl-31150129
ABSTRACT
Patients with a Zellweger spectrum disorder (ZSD) have a defect in the assembly or maintenance of peroxisomes, leading to a multisystem disease with variable outcome. Liver disease is an important feature in patients with severe and milder phenotypes and a frequent cause of death. However, the course and histology of liver disease in ZSD patients are ill-defined. We reviewed the hepatic symptoms and histological findings of 13 patients with a ZSD in which one or several liver biopsies have been performed (patient age 0.2-39 years). All patients had at least some histological liver abnormalities, ranging from minor fibrosis to cirrhosis. Five patients demonstrated significant disease progression with liver failure and early death. In others, liver-related symptoms were absent, although some still silently developed cirrhosis. Patients with peroxisomal mosaicism had a better prognosis. In addition, we show that patients are at risk to develop a hepatocellular carcinoma (HCC), as one patient developed a HCC at the age of 36 years and one patient a precancerous lesion at the age of 18 years. Thus, regular examination to detect fibrosis or cirrhosis should be included in the standard care of ZSD patients. In case of advanced fibrosis/cirrhosis expert consultation and HCC screening should be initiated. This study further delineates the spectrum and significance of liver involvement in ZSDs.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Zellweger Syndrome / Carcinoma, Hepatocellular / Liver / Liver Cirrhosis / Liver Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Zellweger Syndrome / Carcinoma, Hepatocellular / Liver / Liver Cirrhosis / Liver Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2019 Type: Article